{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:29:22Z","timestamp":1753522162236},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00120-019-0949-7","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:16:51Z","timestamp":1559067411000},"page":"634-639","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sakrale Neuromodulation bei unter- und \u00fcberaktivem Detrusor \u2013 quo vadis?"],"prefix":"10.1007","volume":"58","author":[{"given":"F.","family":"Girtner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"issue":"5","key":"949_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/1756287218756082","volume":"10","author":"A Abello","year":"2018","unstructured":"Abello A, Das AK (2018) Electrical neuromodulation in the management of lower urinary tract dysfunction. Evidence, experience and future prospects. Ther Adv Urol 10(5):165\u2013173","journal-title":"Ther Adv Urol"},{"issue":"6","key":"949_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/bju.12972","volume":"116","author":"SW Autiero","year":"2015","unstructured":"Autiero SW, Hallas N, Betts CD et al (2015) The cost-effectiveness of sacral nerve stimulation (SNS) for the treatment of idiopathic medically refractory overactive bladder (wet) in the UK. BJU Int 116(6):945\u2013954","journal-title":"BJU Int"},{"key":"949_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000434671","volume":"29","author":"M Banakhar","year":"2015","unstructured":"Banakhar M, Hassouna M (2015) Sacral Neuromodulation for genitourinary problems. Prog Neurol Surg 29:192\u2013199","journal-title":"Prog Neurol Surg"},{"issue":"S2","key":"949_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/nau.23465","volume":"37","author":"B Blok","year":"2018","unstructured":"Blok B, van Kerrebroeck P, de Wachter S et\u00a0al (2018) Three month clinical results with a\u00a0rechargeable sacral neuromodulation system for the treatment of overactive bladder. Neurourol Urodyn 37(S2):9\u201316","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"949_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/nau.21009","volume":"30","author":"W Chaabane","year":"2011","unstructured":"Chaabane W, Guillotreau J, Castel-Lacanal E et al (2011) Sacral neuromodulation for treating neurogenic bladder dysfunction. Clinical and urodynamic study. Neurourol Urodyn 30(4):547\u2013550","journal-title":"Neurourol Urodyn"},{"key":"949_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13570","author":"J Fassov","year":"2019","unstructured":"Fassov J, Lundby L, Laurberg S et al (2019) Sacral nerve modulation for irritable bowel syndrome. A randomized, double-blinded, placebo-controlled crossover study. Neurogastroenterol Motil. \n                    https:\/\/doi.org\/10.1111\/nmo.13570","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"949_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1464-410X.2007.07258.x","volume":"101","author":"PM Groenendijk","year":"2008","unstructured":"Groenendijk PM, Lycklama \u00e0 Nyeholt AAB, Heesakkers JPFA et\u00a0al (2008) Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence. BJU Int 101(3):325\u2013329","journal-title":"BJU Int"},{"key":"949_CR8","first-page":"109","volume":"10","author":"DA Janssen","year":"2017","unstructured":"Janssen DA, Martens FM, de Wall LL et\u00a0al (2017) Clinical utility of neurostimulation devices in the treatment of overactive bladder. Current perspectives. Med Devices (Auckl) 10:109\u2013122","journal-title":"Med. Devices (Auckl)"},{"key":"949_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.urology.2016.05.032","volume":"97","author":"J Jones","year":"2016","unstructured":"Jones J, van de Putte D, de Ridder D et\u00a0al (2016) A joint mechanism of action for sacral Neuromodulation for bladder and bowel dysfunction? Urology 97:13\u201319","journal-title":"Urology"},{"key":"949_CR10","volume-title":"Diagnostik und Therapie von neurogenen Blasenst\u00f6rungen","author":"WH Jost","year":"2012","unstructured":"Jost WH, Herzog J, Carl S, Haensch CA, J\u00fcnemann KP (2012) Diagnostik und Therapie von neurogenen Blasenst\u00f6rungen. \n                    https:\/\/www.awmf.org\/leitlinien\/detail\/ll\/030-121.html\n                    \n                  . Zugegriffen: 13. Apr. 2019"},{"key":"949_CR11","first-page":"540","volume":"5","author":"TM Kessler","year":"2005","unstructured":"Kessler TM, Burkhard FC, Studer UE (2005) Sakrale Neuromodulation \u2013 letzte Hoffnung bei therapierefrakt\u00e4ren Blasenfunktionsst\u00f6rungen und chronischem Schmerzsyndrom des Beckens? Schweiz Med Forum 5:540\u2013545","journal-title":"Schweiz Med Forum"},{"key":"949_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.urology.2016.06.004","volume":"99","author":"D Liberman","year":"2017","unstructured":"Liberman D, Ehlert MJ, Siegel SW (2017) Sacral Neuromodulation in urological practice. Urology 99:14\u201322","journal-title":"Urology"},{"issue":"9","key":"949_CR13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1111\/j.1743-6109.2008.00948.x","volume":"5","author":"G Lombardi","year":"2008","unstructured":"Lombardi G, Mondaini N, Giubilei G et\u00a0al (2008) Sacral neuromodulation for lower urinary tract dysfunction and impact on erectile function. J\u00a0Sex Med 5(9):2135\u20132140","journal-title":"J Sex Med"},{"issue":"2","key":"949_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.juro.2011.02.2694","volume":"186","author":"T Marcelissen","year":"2011","unstructured":"Marcelissen T, Jacobs R, van Kerrebroeck P et\u00a0al (2011) Sacral neuromodulation as a\u00a0treatment for chronic pelvic pain. J\u00a0Urol 186(2):387\u2013393","journal-title":"J Urol"},{"key":"949_CR15","unstructured":"Medtronic GmbH Interstim Sakrale Neuromodulation. \n                    https:\/\/www.medtronic.com\/de-de\/fachkreise\/therapien-prozeduren\/gastroenterologie-proktologie\/interstim-sakrale-neuromodulation.html\n                    \n                  . Zugegriffen: 15. Apr. 2019"},{"issue":"1","key":"949_CR16","doi-asserted-by":"publisher","first-page":"78.e1","DOI":"10.1016\/j.ajog.2018.04.005","volume":"219","author":"ENB Myer","year":"2018","unstructured":"Myer ENB, Petrikovets A, Slocum PD et al (2018) Risk factors for explantation due to infection after sacral neuromodulation. A multicenter retrospective case-control study. Am J Obstet Gynecol 219(1):78.e1\u201378.e9","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"949_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/nau.23008","volume":"36","author":"KL Noblett","year":"2017","unstructured":"Noblett KL, Dmochowski RR, Vasavada SP et al (2017) Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome. Neurourol Urodyn 36(3):727\u2013733","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"949_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5213\/inj.1836246.123","volume":"22","author":"E Park","year":"2018","unstructured":"Park E, Lee J\u2011W, Kang M et al (2018) Detecting bladder biomarkers for closed-loop neuromodulation. A technological review. Int Neurourol\u00a0J 22(4):228\u2013236","journal-title":"Int Neurourol J"},{"issue":"5","key":"949_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/bju.12571","volume":"113","author":"K Peeters","year":"2014","unstructured":"Peeters K, Sahai A, de Ridder D et al (2014) Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int 113(5):789\u2013794","journal-title":"BJU Int"},{"issue":"1","key":"949_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.juro.2017.07.010","volume":"199","author":"S Siegel","year":"2018","unstructured":"Siegel S, Noblett K, Mangel J et al (2018) Five-year followup results of a\u00a0prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. J\u00a0Urol 199(1):229\u2013236","journal-title":"J Urol"},{"issue":"2","key":"949_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/nau.22938","volume":"36","author":"TLA Hoen","year":"2017","unstructured":"Hoen TLA, Groen J, Scheepe JR et\u00a0al (2017) Intermittent sacral neuromodulation for idiopathic urgency urinary incontinence in women. Neurourol Urodyn 36(2):385\u2013389","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"949_CR22","first-page":"44","volume":"1","author":"EA Tanagho","year":"2012","unstructured":"Tanagho EA (2012) Neuromodulation and neurostimulation. Overview and future potential. Transl Androl Urol 1(1):44\u201349","journal-title":"Transl Androl Urol"},{"key":"949_CR23","first-page":"CD004464","volume":"8","author":"MA Thaha","year":"2015","unstructured":"Thaha MA, Abukar AA, Thin NN et\u00a0al (2015) Sacral nerve stimulation for faecal incontinence and constipation in adults. Cochrane Database Syst Rev 8:CD4464","journal-title":"Cochrane Database Syst Rev"},{"key":"949_CR24","first-page":"20","volume":"17","author":"J Wachter","year":"2010","unstructured":"Wachter J (2010) Invasive Neuromodulation. J\u00a0Urol Urogyn\u00e4kol 17:20\u201321","journal-title":"J Urol Urogyn\u00e4kol"},{"key":"949_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02698-7","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang P, Tian X et\u00a0al (2019) Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder. A prospective randomized controlled trial evaluating the safety and efficacy of a\u00a0novel sacral neuromodulation device. World J Urol. \n                    https:\/\/doi.org\/10.1007\/s00345-019-02698-7","journal-title":"World J Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-019-0949-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-019-0949-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-019-0949-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:34:29Z","timestamp":1590536069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-019-0949-7"}},"subtitle":["Prinzipien und Entwicklungen"],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["949"],"URL":"https:\/\/doi.org\/10.1007\/s00120-019-0949-7","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"28 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Girtner, M.\u00a0Burger und R.\u00a0Mayr geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}